Reaction
Application Site Ulcer reporting signals
As of the last recalculation, Application Site Ulcer appears in 704 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is MINOXIDIL FOAM 5% (WOMENS) (PRR 144.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Minoxidil Foam 5% (Womens) | 131 | 144.0 | 144.6 |
| Minoxidil | 152 | 127.3 | 127.7 |
| Methylphenidate | 19 | 19.9 | 19.9 |
| Nicotine | 22 | 16.6 | 16.6 |
| Buprenorphine | 47 | 16.0 | 16.0 |
| Glycerin, Lidocaine | 7 | 14.9 | 14.9 |
| Docosanol | 7 | 14.3 | 14.3 |
| Asenapine Maleate | 3 | 10.3 | 10.3 |
| Tapentadol Hydrochloride | 7 | 6.2 | 6.2 |